Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Common Stock

$535.72M

Quarterly · Period ending: · USD

LCTX logo

LCTX Common Stock

Latest reported$515.47M
LCTX FY Common Stock ($0.00 → $515.47M)
High-resolution chart · PNG

LCTX common stock history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Common Stock — Annual fiscal periods (USD)
Period endingCommon Stock (USD)
515,467,000
484,722,000
451,343,000
440,280,000
434,529,000
393,944,000
387,062,000
354,270,000
378,487,000
317,878,000
274,342,000
234,842,998
203,456,401
119,821,243
115,144,787
101,135,428
59,722,318
43,184,606
40,704,136
0
40,251,097
38,718,197
32,857,552
32,374,883
30,602,003
28,360,007
27,200,380
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.